Entity Common Stock, Shares Outstanding of LAVA Therapeutics NV from 31 Dec 2021 to 03 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
LAVA Therapeutics NV quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Dec 2021 to 03 Nov 2025.
  • LAVA Therapeutics NV Entity Common Stock, Shares Outstanding for the quarter ending 03 Nov 2025 was 26,305,295.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

LAVA Therapeutics NV Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 26,305,295 03 Nov 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 26,305,295 08 Aug 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 26,305,295 21 Mar 2025 10-K 28 Mar 2025 2024 FY
Q4 2023 26,289,087 0 0% 31 Dec 2023 20-F 20 Mar 2024 2023 FY
Q4 2022 26,289,087 +513,549 +2% 31 Dec 2022 20-F 11 Apr 2023 2022 FY
Q4 2021 25,775,538 31 Dec 2021 20-F/A 23 Dec 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.